KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Return on Assets: 2011-2025

Historic Return on Assets for Nektar Therapeutics (NKTR) over the last 14 years, with Sep 2025 value amounting to -0.45%.

  • Nektar Therapeutics' Return on Assets rose 7.00% to -0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.45%, marking a year-over-year increase of 7.00%. This contributed to the annual value of -0.34% for FY2024, which is 16.00% up from last year.
  • Nektar Therapeutics' Return on Assets amounted to -0.45% in Q3 2025, which was up 10.50% from -0.50% recorded in Q2 2025.
  • Over the past 5 years, Nektar Therapeutics' Return on Assets peaked at -0.29% during Q1 2021, and registered a low of -0.66% during Q1 2023.
  • Moreover, its 3-year median value for Return on Assets was -0.50% (2025), whereas its average is -0.53%.
  • Per our database at Business Quant, Nektar Therapeutics' Return on Assets declined by 22bps in 2022 and then increased by 27bps in 2024.
  • Over the past 5 years, Nektar Therapeutics' Return on Assets (Quarterly) stood at -0.44% in 2021, then fell by 6bps to -0.50% in 2022, then dropped by 15bps to -0.66% in 2023, then increased by 27bps to -0.39% in 2024, then climbed by 7bps to -0.45% in 2025.
  • Its Return on Assets stands at -0.45% for Q3 2025, versus -0.50% for Q2 2025 and -0.46% for Q1 2025.